Parallax Volatility Advisers, L.P. Chemo Centryx, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$15.36 - $27.51 $872,448 - $1.56 Million
-56,800 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$22.22 - $39.12 $1.26 Million - $2.22 Million
56,700 Added 56700.0%
56,800 $1.42 Million
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $446,634 - $984,150
-24,300 Reduced 99.59%
100 $4,000
Q3 2021

Nov 15, 2021
BUY
$13.18 - $19.83 $321,592 - $483,851
24,400 New
24,400 $417,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email